Article Information
History
- August 1, 2021.
Article Versions
- Version 1 (July 6, 2021 - 10:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ralf Duerr, MD, PhD1,*,
- Dacia Dimartino, PhD2,
- Christian Marier2,
- Paul Zappile2,
- Guiqing Wang, MD, PhD3,
- Jennifer Lighter, MD4,
- Brian Elbel, PhD5,
- Andrea Troxel, PhD5 and
- Adriana Heguy, PhD2,3,*
- 1Department of Microbiology, NYU Grossman School of Medicine
- 2Genome Technology Center, Office of Science and Research, NYU Langone Health
- 3Department of Pathology, NYU Grossman School of Medicine
- 4Department of Pediatric Infectious Diseases, NYU Grossman School of Medicine
- 5Department of Population Health, NYU Grossman School of Medicine
- ↵*Co-corresponding authors Correponding authors: Ralf Duerr, MD, PhD, Department of Microbiology, NYU Grossman School of Medicine, Alexandria Center for Life Science (ACLS), West Tower, 430 East, 29th Street, Room 323, Email: ralf.duerr{at}nyulangone.org, Tel: 212-263-4159, Adriana Heguy, PhD, Department of Pathology, NYU Grossman School of Medicine, Genome Technology Center, NYU Langone Health, 550 First Avenue, MSB 294A, New York, NY 10018, Email: adriana.heguy{at}nyulangone.org, Tel: 212-263-8048
Posted August 01, 2021.
Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City
